01-Feb-16 At the 2012 Yeosu Expo, SK Telecom showcased its vision for remote healthcare. But "zero progress has been made on the smart health platform” said a manager at SK Telecom this year. “There is nothing we... can do about it because the law prohibiting remote diagnosis and treatment of patients remains unchanged." [image: Joongang Ilbo]

30-Jan-16 How big is the potential market for diabetes drugs in China? As big as the entire populations of Australia, Canada and Argentina combined. And it's growing. Only about half of China’s diabetics have been diagnosed, and only 15% of those diagnosed are receiving comprehensive treatment, said Jakob Riis, head of China at Novo Nordisk, the world’s largest insulin maker. [image: AFP / Getty Images]

28-Jan-16 Seoul National University Bundang Hospital kept track of 99 diabetes patients aged 60+ for six months and found that those managed with its voice-recognition U-healthcare system showed a glycated hemoglobin level 8.5% lower than that of the control group. According to the hospital, this system can improve blood sugar management efficiency and help prevent diabetic complications. [image: Business Korea]

18-Jan-16 As the healthcare industry considers the possibilities - and challenges - of the year ahead, here's a look back at 12 notable Healthcare growth markets stories from 2015 you may have missed, month-by-month, including "China’s physicians encouraged to take up second jobs", "Vietnam achieves healthcare Millennium Development Goals", "World's biggest healthcare facility financed in Turkey" and more.

21-Jan-16 LG Life Sciences will start selling Korea's first diabetes treatment Zemiglo in the global market this year. The Korean drugmaker sealed licensing partnerships with Sanofi and Stendhal in 2013, and will begin selling the new treatment in India and five countries in Central America from March 2016. [image: LG / Business Korea]